2002•Chinese Journal of Oral & Maxillofacial SurgeryRequires access

MUTAGENESIS OF GENE-TRANSDUCED CELL TCA8113/TNF-α IN VITRO

Ming Fan

Open publisher page 0 citations

Abstract

Objective To investigate the safety of gene transduced Tca8113/TNF α as tumor vaccine. Methods TNF α gene was transduced into Tca8113. The mutagenesis of the DNA and supermatant of Tca8113/TNF α in vitro was tested by means of genetic toxicological techniques — the Ames assays. Results (1)?The hightest number (x±s) of the bacteria clone of the DNA groups were 150 5±11 2/160 2±7 6 (TA97); 34 0±2 2/34 4±3 2 (TA98); 139 8±4 6/130 8±7 2 (TA100); 264 0±14 6/254 4±8 2 (TA102)。(2)?The highest number (x±s) of the bacteria clone of the supernatant groups were 140 5±11 2/155 2±7 6 (TA97); 34 0±1 0/36 4±7 2 (TA98); 145 6±5 6/164 4±6 2 (TA100); 254 0±6 0/284 4±8 2 (TA102)。 Conclusion The mutagenesis of both the DNA and supermatant of transgenic cell Tca8113/TNF α was not observed. The initial experiment suggested that the application of gene transduced cell Tca8113/TNF α as tumor vaccine was basically safe and reliable.

About this research paper

What this paper is about

Objective To investigate the safety of gene transduced Tca8113/TNF α as tumor vaccine. Methods TNF α gene was transduced into Tca8113. The mutagenesis of the DNA and supermatant of Tca8113/TNF α in vitro was tested by means of genetic toxicological techniques — the Ames assays. Results (1)?The hightest number (x±s) of the bacteria clone of the DNA groups were 150 5±11 2/160 2±7 6 (TA97); 34 0±2 2/34 4±3 2 (TA98); 139 8±4 6/130 8±7 2 (TA100); 264 0±14 6/254 4±8 2 (TA102)。(2)?The highest number (x±s) of the bacteria clone of the supernatant groups were 140 5±11 2/155 2±7 6 (TA97); 34 0±1 0/36 4±7 2 (TA98); 145 6±5 6/164 4±6 2 (TA100); 254 0±6 0/284 4±8 2 (TA102)。 Conclusion The mutagenesis of both the DNA and supermatant of transgenic cell Tca8113/TNF α was not observed. The initial experiment suggested that the application of gene transduced cell Tca8113/TNF α as tumor vaccine was basically safe and reliable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the safety of gene transduced Tca8113/TNF α as tumor vaccine. Methods TNF α gene was transduced into Tca8113. The mutagenesis of the DNA and supermatant of Tca8113/TNF α in vitro was tested by means of genetic toxicological techniques — the Ames assays. Results (1)?The hightest number (x±s) of the bacteria clone of the DNA groups were 150 5±11 2/160 2±7 6 (TA97); 34 0±2 2/34 4±3 2 (TA98); 139 8±4 6/130 8±7 2 (TA100); 264 0±14 6/254 4±8 2 (TA102)。(2)?The highest number (x±s) of the bacteria clone of the supernatant groups were 140 5±11 2/155 2±7 6 (TA97); 34 0±1 0/36 4±7 2 (TA98); 145 6±5 6/164 4±6 2 (TA100); 254 0±6 0/284 4±8 2 (TA102)。 Conclusion The mutagenesis of both the DNA and supermatant of transgenic cell Tca8113/TNF α was not observed. The initial experiment suggested that the application of gene transduced cell Tca8113/TNF α as tumor vaccine was basically safe and reliable.

Key concepts: Mutagenesis, clone (Java method), Gene, Molecular biology, Tumor necrosis factor alpha, Biology, DNA, In vitro

Related papers

Back to paper searchBrowse research topicsOriginal source
MUTAGENESIS OF GENE-TRANSDUCED CELL TCA8113/TNF-α IN VITRO — Research Paper | ScholarLens